• Bevacizumab - CIZUMAB

Bevacizumab - CIZUMAB

  • Bevacizumab
  • Avastin
  • 100mg & 400mg
  • Hetero Pharma

Cizumab (Bevacizumab) is available in a single dose vial with two strengths, 100 mg and 400 mg.

Cizumab (Bevacizumab) biosimilar of Avastin is manufactured by Hetero Pharma

Cizumab (Bevacizumab) biosimilar of Avastin, is medication used to treat a number of types of cancers and a specific eye disease. For cancer Cizumab (Bevacizumab) is given by slow injection into a vein and used for colon cancer, lung cancer, glioblastoma, and renal-cell carcinoma. For age-related macular degeneration Cizumab (Bevacizumab) is given by injection into the eye. It works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth.

Cizumab (Bevacizumab) will be manufactured in Hetero Pharma's dedicated state-of-the-art biologics facility based in Hyderabad, India.